*Offer includes BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) for Dogs or BRAVECTO® (fluralaner) Chews  only   

Program Terms & Conditions:  Offer valid for purchases made between 1/1/2026 and 12/31/2026. To receive your rebate fulfilled via Merck Visa® Prepaid Card, all fields must be completed online or via mail-in rebate form. Original, itemized veterinary invoice with product purchased, purchase price, purchase date, and invoice number circled must accompany the submission. Rebate request must be submitted on or before 1/31/2027. Veterinary invoice must reflect a purchase of at least one (1) dose of BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) for Dogs or BRAVECTO® (fluralaner) Chews only

Only one (1) offer can be redeemed per invoice and this offer cannot be combined with other offers. Limit one (1) rebate submission per pet and limit four (4) per household, address or person, and right is reserved to confirm identity. Offer may only be redeemed by the pet owner, who must be 18 years or older to redeem. Offer available on purchases from clinics in the fifty (50) United States or the District of Columbia only. Purchases from online pharmacies or other retail outlets not associated with your veterinary clinic are not valid. Merck Animal Health reserves the right to decline submissions for purchases from unauthorized distributors.

Void where prohibited by law. Please allow up to eight (8) weeks for rebate delivery. Rebate will be fulfilled via Merck Visa Prepaid Card.

Card is issued by Pathward, N.A., Member FDIC, pursuant to a license from Visa U.S.A. Inc. No cash access or recurring payments. Can be used everywhere Visa debit cards are accepted. Card valid for up to 6 months; unused funds will forfeit after the valid through-date. Card terms and conditions apply. Please allow up to 8 weeks for delivery of the rebate. For rebate inquiries call 855-496-0146 or visit rewards.mypet.com.

By submitting this rebate, I agree to receive information on products and services from Merck Animal Health and its subsidiaries. My account information may also be used to deliver tailored social media ads. I can manage my communication preferences at any time by clicking on the link at the bottom of my email at any time.

Important Safety Information

Important Safety Information

BRAVECTO (fluralaner) Chews for Dogs: The most commonly reported adverse reactions include vomiting, lethargy, diarrhea, anorexia and pruritus. In some cases, adverse events have been reported following use in breeding females. BRAVECTO Chews has not been shown to be effective for 12-weeks’ duration in puppies less than 6 months of age. BRAVECTO Chews is not effective against lone star ticks beyond 8 weeks of dosing. Indicated for dogs 6 months of age and older.  BRAVECTO 1-MONTH (fluralaner) Chews: The most commonly reported adverse reactions include itching, diarrhea, vomiting, decreased appetite, elevated ALT, lethargy, and weight loss. Not effective against lone star ticks in puppies less than 6 months of age. Indicated for dogs 8 weeks of age and older. BRAVECTO QUANTUM (fluralaner for extended-release injectable suspension) for Dogs: The most commonly reported adverse reactions in a US field study included lethargy, decreased appetite, vomiting, diarrhea, elevated liver enzymes and pruritus. BRAVECTO QUANTUM is not effective against lone star ticks beyond 8 months of dosing. Indicated for dogs 6 months of age and older. 

All BRAVECTO products contain fluralaner, which is a member of the isoxazoline class.  This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures.  Seizures have been reported in dogs receiving isoxazoline class drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders.

SENTINEL SPECTRUM Chews (milbemycin oxime/lufenuron/praziquantel). Dogs should be tested for heartworm prior to use. Mild hypersensitivity reactions have been noted in some dogs carrying a high number of circulating microfilariae. Treatment with fewer than 6 monthly doses after the last exposure to mosquitoes may not provide complete heartworm prevention. For complete product information refer to the product insert.